Relying solely on immune checkpoint inhibitors may not effectively treat pancreatic cancer, likely because of the tumor’s low levels of PD-L1 expression, intricate interactions between the tumor and its surrounding stroma, and dense fibrotic environment. Here, CD274 is linked to familial pancreatic carcinoma.